Effect of Esmolol on Clinical Outcomes in Critically Ill Patients: Data from the MIMIC-IV Database

被引:2
作者
Liang, Qihong [1 ,2 ]
Li, Lulan [1 ,3 ]
Chen, Kerong [1 ]
An, Sheng [1 ]
Deng, Zhiya [1 ]
Li, Jiaxin [1 ]
Zhou, Shiyu [1 ,2 ]
Chen, Zhongqing [1 ]
Zeng, Zhenhua [1 ,3 ,4 ]
An, Shengli [2 ,5 ]
机构
[1] Southern Med Univ, Nanfang Hosp, Dept Crit Care Med, Guangzhou, Peoples R China
[2] Southern Med Univ, Sch Publ Hlth, Dept Biostat, Guangdong Prov Key Lab Trop Dis Res, Guangzhou, Guangdong, Peoples R China
[3] Southern Med Univ, Dept Pathophysiol, Guangdong Prov Key Lab Shock & Microcirculat, Guangzhou, Peoples R China
[4] Southern Med Univ, Nanfang Hosp, Dept Crit Care Med, Guangzhou 510515, Peoples R China
[5] Southern Med Univ, Sch Publ Hlth, Dept Biostat, Guangdong Prov Key Lab Trop Dis Res,Guangdong Prov, 1838 North Guangzhou Ave, Guangzhou 510515, Peoples R China
关键词
esmolol; critically ill; mortality; vasopressor; MIMIC database; SEPTIC SHOCK; HEART-RATE; BETA-BLOCKER; HYPERTENSION; TACHYCARDIA;
D O I
10.1177/10742484231185985
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aimsEsmolol is a common short-acting drug to control ventricular rate. This study aimed to evaluate the association between use of esmolol and mortality in critically ill patients. MethodsThis is a retrospective cohort study from MIMIC-IV database containing adult patients with a heart rate of over 100 beats/min during the intensive care unit (ICU) stay. Multivariable Cox proportional hazard models and logistic regression were used to explore the association between esmolol and mortality and adjust confounders. A 1:1 nearest neighbor propensity score matching (PSM) was performed to minimize potential cofounding bias. The comparison for secondary outcomes was performed at different points of time using an independent t-test. ResultsA total of 30,332 patients were reviewed and identified as critically ill. There was no significant difference in 28-day mortality between two groups before (HR = 0.90, 95% CI = 0.73-1.12, p = 0.343) and after PSM (HR = 0.84, 95% CI = 0.65-1.08, p = 0.167). Similar results were shown in 90-day mortality before (HR = 0.93, 95% CI = 0.75-1.14, p = 0.484) and after PSM (HR = 0.85, 95% CI = 0.67-1.09, p = 0.193). However, esmolol treatment was associated with higher requirement of vasopressor use before (HR = 2.89, 95% CI = 2.18-3.82, p < 0.001) and after PSM (HR = 2.66, 95% CI = 2.06-3.45, p < 0.001). Esmolol treatment statistically reduced diastolic blood pressure (DBP), mean arterial pressure (MAP), and heart rate (all p < 0.001) and increased fluid balance at 24 hours (p < 0.05) but did not significantly lower SBP (p = 0.721). Patients in esmolol group showed no significant difference in lactate levels and daily urine output when compared with those in non-esmolol group when adjusted for confounders (all p > 0.05). ConclusionEsmolol treatment was associated with reduced heart rate and lowered DBP and MAP, which may increase vasopressor use and fluid balance at the timepoint of 24 hours in critically ill patients during ICU stay. However, after adjusting for confounders, esmolol treatment was not associated with 28-day and 90-day mortality.
引用
收藏
页数:8
相关论文
共 50 条
[31]   A retrospective study utilized MIMIC-IV database to explore the potential association between triglyceride-glucose index and mortality in critically ill patients with sepsis [J].
Lou, Jiaqi ;
Xiang, Ziyi ;
Zhu, Xiaoyu ;
Fan, Youfen ;
Song, Jingyao ;
Cui, Shengyong ;
Li, Jiliang ;
Jin, Guoying ;
Huang, Neng .
SCIENTIFIC REPORTS, 2024, 14 (01)
[32]   U-shaped relationship between serum phosphate levels and mortality in critically ill patients with atrial fibrillation: Insights from the MIMIC-IV database [J].
He, Yinying ;
Huang, Jiamei ;
Huang, Senlin ;
Li, Yuewei ;
Li, Qintong ;
Lin, Zhineng ;
Huang, Tucheng ;
Huang, Fuwen .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2025, 433
[33]   Effect of methylprednisolone vs hydrocortisone on 30-day mortality in critically ill adults with septic shock: an analysis of the MIMIC-IV database [J].
Xu, Jun ;
Cai, Hongliu ;
Zheng, Xia .
BMC INFECTIOUS DISEASES, 2025, 25 (01)
[34]   Monitoring vancomycin blood concentrations reduces mortality risk in critically ill patients: a retrospective cohort study using the MIMIC-IV database [J].
Peng, Huaidong ;
Ou, Yuantong ;
Zhang, Ruichang ;
Wang, Ruolun ;
Wen, Deliang ;
Yang, Qilin ;
Liu, Xiaorui .
FRONTIERS IN PHARMACOLOGY, 2024, 15
[35]   Association between body mass index and delirium incidence in critically ill patients: a retrospective cohort study based on the MIMIC-IV Database [J].
Fu, Jianlei ;
Zhang, Xuepeng ;
Zhang, Geng ;
Wei, Canzheng ;
Fu, Qinyi ;
Gui, Xiying ;
Ji, Yi ;
Chen, Siyuan .
BMJ OPEN, 2024, 14 (03)
[36]   Association between the triglyceride glucose index and the risk of acute kidney injury in critically ill patients with hypertension: analysis of the MIMIC-IV database [J].
Zhang, Wenbin ;
Yang, Zewen .
FRONTIERS IN ENDOCRINOLOGY, 2024, 15
[37]   Effect of Serum Phosphate on the Prognosis of Septic Patients: A Retrospective Study Based on MIMIC-IV Database [J].
Li, Zhaoyang ;
Shen, Tingwen ;
Han, Yi .
FRONTIERS IN MEDICINE, 2022, 9
[38]   Association Between Serum Anion Gap and Mortality in Critically Ill Patients with COPD in ICU: Data from the MIMIC IV Database [J].
Chen, Xiaojing ;
Yang, Qilin ;
Gao, Li ;
Chen, Weinan ;
Gao, Xiaoyu ;
Li, Yameng ;
Ao, Liying ;
Sun, Dejun .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 :579-587
[39]   Association between BMI and outcomes in critically ill patients: an analysis of the MIMIC-III database [J].
Yu, Wenbo ;
Jiang, Weiwei ;
Yuan, Jihong ;
Fan, Tao ;
Xiao, Huiyan ;
Sun, Lizhu ;
Zhu, Yan ;
Li, Wenfang ;
Wu, Shaoshuai .
SCIENTIFIC REPORTS, 2024, 14 (01)
[40]   Stress hyperglycemia ratio and 30-day mortality among critically ill patients with acute heart failure: analysis of the MIMIC-IV database [J].
You, Xiaodong ;
Zhang, Hengzhi ;
Li, Tianshi ;
Zhu, Yi ;
Zhang, Zhongman ;
Chen, Xufeng ;
Huang, Peipei .
ACTA DIABETOLOGICA, 2025,